Authors
Latest:
Payers Believe Lowering Drug Prices While Improving Patient Access Is Possible—but There’s a CatchValue-based price for access (VBPA) may increase access of specialty drugs for patients.
Latest:
The Truth About TelemedicineScott Morano explores some of the challenging questions brands will need to ask in light of an HCP switch to telemedicine.
Latest:
When Innovation Outpaces HTA, Access Struggles to Keep UpScientific advances are benefiting cancer patients, but it will take a pandemic-like response to ensure patients everywhere have access.
Latest:
The Rise of Longevity TherapeuticsThe field of longevity therapeutics — with the goal “of not just adding years to life but adding life to years” — is already disrupting the medical industry, writes Marco Quarta.
Latest:
5 Digital Trends You Need to Adopt This Year to Remain Top of MindEnsure your tactical plan is up to the new, innovative standards that your audience expects from their digital experience with your brand.
Latest:
Changing the Paradigm in AI ImplementationHow pharma companies can reduce the risk of failure with AI-based innovations.
Latest:
How Market Access Can Determine Commercial SuccessUsing market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.
Latest:
Military Veterans in Pharma: Serving to Improve LivesMilitary veterans exemplify traits valuable to pharma industry.
Latest:
Building Resiliency: Essential Leadership Principles for 2024Embracing business imperatives such as operational efficiency and a focus on a patient-centric approach can help pharma leaders provide a stable foundation amid lingering uncertainty.
Latest:
FDA Inspection and Enforcement Developments During the COVID-19 PandemicMitigating the risks of development, authorization, and marketing for new therapies following "new normal" created by COVID-related violations.
Latest:
Janssen, Johns Hopkins Partner on Dermatology Ethnic Skin ProgramJanssen, Johns Hopkins Dermatology’s Ethnic Skin Fellowship Program partnership focuses on improving clinical care and advancing research for skin-of-color patients.
Latest:
Cultivating UK Life Sciences Collaboration and Innovation2021‘s Pharmaceutical Industry Network Group (PING) conference focused on the UK’s COVID-19 response and how it can continue as a leader in science innovation and collaboration, including opportunities through use of health and genomic data.
Latest:
Thriving ‘Beyond the Pill’: Closing Key Gap in Patient SupportWhy pharma needs to focus on improving—not just extending life.
Latest:
The Global Vaccine R&D Pipeline and Delivery ImplicationsThe current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
Latest:
Pushing Boundaries to Revolutionize Chronic Inflammation TherapyNovel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.
Latest:
The EU Regulations Catching US Pharma Companies Off GuardCompanies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.
Latest:
Specialty Value-Based Care is Improving Health Outcomes While Reducing Heath Care CostsDelivering value-based care is expected to become even more prevalent, driven by factors such as patient comfort with digital tools and advancements in contractual arrangements.
Latest:
Balancing Marketability and Risk in a Drug NameNavigating the challenging landscape of pharmaceutical naming—where a name must meet regulatory approval, clear trademark hurdles, and capture market attention all at once.
Latest:
A Single Source of Truth for KOL MappingCoordination of KOL engagement is all but impossible if the information an organization collects about them is fragmented. What is needed is a centralized database that captures all information about an expert from the multiple touch points across functions and geographies.
Latest:
How Open-Source Benefits Clinical TrialsAs therapeutics become more personalized and targeted, technology, such as open-source software, can help companies innovate.
Latest:
Addressing Health Disparities Through Robust Patient Support ProgramsIdentifying unique traits in patients is key to creating the most effective support programs.
Latest:
Reimbursement Benchmark Share: An Objective Measure of the Impact of Product Reimbursement on Sales PerformanceKnowing that product reimbursement affects performance and varies by geography, this article proposes the use of Reimbursement Benchmark Share (RBS) to quantify the influence of reimbursement on a product’s performance.
Latest:
The Leap Forward: Practical Gains for Pharma AI UseExploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.
Latest:
Open Science and Digital Health: A Brighter Future for Parkinson’s DiseaseCollaborative efforts among researchers, clinicians, and industry are essential to unlock the full potential of digital health in transforming the lives of people with Parkinson's disease.
